Experimental Treatment Reduces Retinal Thinning in Progressive Multiple Sclerosis
source: pixabay.com

Experimental Treatment Reduces Retinal Thinning in Progressive Multiple Sclerosis

According to a story from GlobeNewswire, the biopharmaceutical company MediciNova, Inc. has announced encouraging results related in Optical Coherence Tomography (OCT) in a phase 2b clinical trial. This clinical trial…

Continue Reading Experimental Treatment Reduces Retinal Thinning in Progressive Multiple Sclerosis